Open AccessThis article is
- freely available
Does Melatonin Homeostasis Play a Role in Continuous Epigastric Pain Syndrome?
Department of Gastroenterology, Medical University of Lodz, 1 Haller's Square, 90-647 Lodz, Poland
Department of Molecular Genetics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland
Department of Clinical Nutrition, Medical University of Lodz, 1 Haller's Square, 90-647 Lodz, Poland
* Author to whom correspondence should be addressed.
Received: 5 March 2013; in revised form: 22 April 2013 / Accepted: 16 May 2013 / Published: 14 June 2013
Abstract: Two clinical forms of functional dyspepsia (FD) are listed in the Rome III criteria: postprandial distress syndrome (PDS) and epigastric pain syndrome (EPS), differing in the recurrence of ailments depending on the diet. Continuous EPS (CEPS) is observed in some EPS patients, also at night, but its cause is still unknown. We showed previously that melatonin (MEL) homeostasis may be associated with FD. In the present work we evaluated selected components of melatonin homeostasis in patients with CEPS. The study included 30 patients with CEPS, 21 women and nine men, aged 21–49 years and 30 control subjects (EPS excluded); organic and mental diseases, as well as Helicobacter pylori infection, were excluded in both groups. The average severity of abdominal pain in the last three months was estimated in a 10-point scale (Visual Analog Scale). The levels of mRNA expression of arylalkylamine-N-acetyltransferase (AANAT) and hydroxyindole-O-methyltransferase (HIOMT), the main components of MEL homeostasis, were determined in gastric mucosa with real time PCR. The fasting serum level of MEL (at 09:00 a.m.) and circadian urine excretion of 6-sulfatoxymelatonin (6-HMS) were determined with ELISA. AANAT expression in antral mucosa of control subjects was 1.76 ± 0.41, in the gastric body 1.35 ± 0.38, and in the dyspeptic group 1.42 ± 0.38 (p < 0.05) and 0.92 ± 0.55 (p < 0.05), respectively. HIOMT expression in the control was 2.05 ± 0.70 in the antrum and 1.57 ± 0.69 in the body and in the CEPS group, it was: 1.51 ± 0.57 (p < 0.05) and 0.74 ± 0.31 (p < 0.001), respectively. MEL concentration (pg/mL) was 9.41 ± 3.09 in the control group and 5.62 ± 1.34 (p < 0.01) in the CEPS group. Urinary 6-HMS excretion (μg/24 h) was 11.40 ± 4.46 in the controls and 7.68 ± 2.88 (p < 0.05) in the CEPS. Moreover, a negative correlation was found between the tested parameters and severity of epigastric pain. These results indicate that patients with CEPS may display low level of AANAT and HIOMT expression in gastric mucosa, resulting in decreased MEL synthesis.
Keywords: continuous epigastric pain syndrome; AANAT; HIOMT; melatonin; 6-sulfatoxymelatonin
Citations to this Article
Cite This Article
MDPI and ACS Style
Chojnacki, C.; Poplawski, T.; Blasiak, J.; Chojnacki, J.; Klupinska, G. Does Melatonin Homeostasis Play a Role in Continuous Epigastric Pain Syndrome? Int. J. Mol. Sci. 2013, 14, 12550-12562.
Chojnacki C, Poplawski T, Blasiak J, Chojnacki J, Klupinska G. Does Melatonin Homeostasis Play a Role in Continuous Epigastric Pain Syndrome? International Journal of Molecular Sciences. 2013; 14(6):12550-12562.
Chojnacki, Cezary; Poplawski, Tomasz; Blasiak, Janusz; Chojnacki, Jan; Klupinska, Grazyna. 2013. "Does Melatonin Homeostasis Play a Role in Continuous Epigastric Pain Syndrome?" Int. J. Mol. Sci. 14, no. 6: 12550-12562.